Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

3 shares for the ASX recovery: SOL, JHC, BUB

The ASX is recovering and now investors are looking at trying to find bargain shares.

Some of the highest quality shares like CSL (ASX: CSL) and Altium (ASX: ALU) have seen their share prices recover strongly since 23 March 2020. You can’t go terribly wrong holding those growth ideas, but there are plenty of shares that are still priced a lot lower.

Here are three ideas for the recovery:

WHSP (ASX: SOL)

A 22% drop of the WHSP share price since the beginning of the market drop has made the old investment house more attractively priced. For decades it has been paying a solid dividend but it has also been re-investing a portion of cash profits back into the business year after year for more growth.

It has survived crisis after crisis over the decades. This is different to the typical economic recession, but with large investments in a telco, a pharmacy business, a coal miner and a diverse property business, it seems defensive. The growing dividend is an attractive bonus.

Japara Healthcare (ASX: JHC)

Japara has been a tough share for a long time. Between 18 March 2020 and now the Japara share price has fallen 48.5%. There are obvious fears that COVID-19 could cause a terrible toll on its resident population. The Aged Care Royal Commission is also probably going to be a negative for the industry.

But, Australia seems to have gotten COVID-19 largely under control. Japara may have removed its guidance recently, but it is prepared for COVID-19 and its occupancy is in line with February 2020 with 4,127 residents which continue to generate fees for Japara.

It also owns its property portfolio and is currently selling two properties and then leasing/renting them. The proceeds will raise $13.3 million and $3.6 million.

There’s underlying value to Japara which I don’t think the market is appreciating at a share price of $0.50.

Bubs Australia (ASX: BUB)

Bubs is a fast-growing infant formula business which specialises with goat milk products. It’s the companies that are producing the essential products that people need to consume that are seeing high demand. Bubs is one that is seeing strong demand for its products.

Despite the continuing demand, Bubs’ share price has fallen to $0.77 at the time of writing. The half-year results was impressive with 37% growth of revenue and 77% growth of infant formula revenue. And the infant formula gross margin increased to 41% (up 5 basis points). The overall gross margin increased from 19% last year to 24% this year.

A business that has a large total addressable market, new products, fast-growing revenue, rising margins and focused leadership is worth keeping an eye on.

Summary

These three ideas have their different strengths and weaknesses. In my opinion, Bubs is the one most likely to deliver big returns over the next five years because of its growth trajectory. WHSP is something you could hold for decades. Japara would be a high-risk, high-reward idea if it can keep generating decent profits. But technology shares could recover even stronger than any of my ideas:

[ls_content_block id=”18457″ para=”paragraphs”]

Disclosure: At the time of writing, Jaz owns shares of WHSP and Altium at the time of writing, but this could change at any time.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content